Atherton Lane Advisers’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$543K Buy
10,772
+73
+0.7% +$3.68K 0.03% 138
2015
Q3
$504K Buy
10,699
+800
+8% +$42.5K 0.03% 143
2015
Q2
$538K Sell
9,899
-623
-6% -$34.9K 0.03% 142
2015
Q1
$577K Buy
10,522
+229
+2% +$13K 0.03% 158
2014
Q4
$558K Buy
10,293
+155
+2% +$8.64K 0.03% 168
2014
Q3
$573K Buy
10,138
+212
+2% +$11.9K 0.03% 168
2014
Q2
$548K Buy
9,926
+1,219
+14% +$66.5K 0.03% 175
2014
Q1
$472K Sell
8,707
-25
-0.3% -$1.29K 0.03% 106
2013
Q4
$417K Sell
8,732
-429
-5% -$19.6K 0.03% 108
2013
Q3
$416K Sell
9,161
-29
-0.3% -$1.32K 0.03% 97
2013
Q2
$407K Buy
+9,190
New +$410K 0.03% 99

Other funds holding MRK

Atherton Lane Advisers's MRK Position: Q4 2015 in Review

Atherton Lane Advisers increased its Merck (MRK) stake by 0.68% in Q4 2015, buying an estimated $3.68K and bringing the position to 10,772 shares worth $543K. The position accounts for 0.03% of the portfolio, ranked #138.

Atherton Lane Advisers first reported a position in MRK in Q2 2013 and has held it in 11 quarters since. The position peaked at $577K in Q1 2015. 1,754 funds tracked by Wall St. Rank hold MRK as of Q4 2015.

  • Atherton Lane Advisers held 10,772 shares of Merck worth $543K as of Q4 2015.
  • Atherton Lane Advisers bought 73 Merck shares in Q4 2015, an estimated $3.68K.
  • Merck made up 0.03% of Atherton Lane Advisers's portfolio in Q4 2015, its #138 holding.
  • Atherton Lane Advisers first reported a position in Merck in Q2 2013 and has held it in 11 quarters since.
  • Atherton Lane Advisers's Merck position peaked at $577K in Q1 2015.
  • 1,754 funds tracked by Wall St. Rank held Merck as of Q4 2015.

Based on Atherton Lane Advisers's 13F filing for Q4 2015, filed 16 Feb 2016.